MST Access initiates coverage of Race Oncology
MST Access has initiated coverage of Race Oncology with a current $4.88 per share valuation….
Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.
ASX Announcements
Share Price
Latest News
Race Oncology’s 2020 AGM
Race Oncology Limited (ASX: RAC) is pleased to release an extended version of the presentation…
‘Three Pillar’ Strategic Update
Race Oncology is pleased to release our updated strategic plan for the clinical advancement of…
Phase II Bisantrene trial data published in European Journal of Haematology
10 November 2020 – Race Oncology Limited (ASX: RAC) is pleased to report that the…
Phase II Bisantrene trial data to be presented at ASH 2020
5 November 2020 – Race Oncology Limited (ASX: RAC) is pleased to report that the…
Prof. Borje S. Andersson appointed Chief Medical Officer
Race Oncology Limited is pleased to announce that Professor Borje S. Andersson has agreed to…
